Literature DB >> 12727647

The role of relB in regulating the adaptive immune response.

Maurizio Zanetti1, Paola Castiglioni, Stephen Schoenberger, Mara Gerloni.   

Abstract

Dendritic cells (DCs), which represent a key type of antigen-presenting cell (APC), are important for the development of innate and adaptive immunity. DCs are involved in T cell activation in at least two main ways: priming via direct processing/presentation of soluble antigen taken up from the microenvironment (conventional priming), and processing/presentation of antigen released from other cells (cross-priming). relB, a component of the NF-kappaB complex of transcription factors, is a critical regulator of the differentiation of DCs. In mice, lack of relB impairs DCs derived from bone marrow both in number and function. Here relB (-/-) bone marrow chimera mice is used to study the APC function of residual DCs in presentation of soluble antigen and cross-priming. It is found that the DCs in these mice are profoundly deficient in their ability to both prime and cross-prime T cell responses. It was concluded that the relB gene is involved in regulating the APC function of DCs in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727647     DOI: 10.1111/j.1749-6632.2003.tb06056.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  16 in total

Review 1.  Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.

Authors:  Yunpeng Zhao; Aijun Zhang; Hongxia Du; Shuya Guo; Bin Ning; Shangyou Yang
Journal:  Rheumatol Int       Date:  2011-09-09       Impact factor: 2.631

2.  Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter.

Authors:  Xiangyang Dong; Ward Lutz; Tania M Schroeder; Lori A Bachman; Jennifer J Westendorf; Rajiv Kumar; Matthew D Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-20       Impact factor: 11.205

3.  T cell immunity using transgenic B lymphocytes.

Authors:  Mara Gerloni; Marta Rizzi; Paola Castiglioni; Maurizio Zanetti
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-02       Impact factor: 11.205

4.  Modulation of nuclear factor-kappaB activity can influence the susceptibility to systemic lupus erythematosus.

Authors:  Alexis M Kalergis; Mirentxu I Iruretagoyena; Magaly J Barrientos; Pablo A González; Andres A Herrada; Eduardo D Leiva; Miguel A Gutiérrez; Claudia A Riedel; Susan M Bueno; Sergio H Jacobelli
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

5.  Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).

Authors:  Hilka Rauert; Andreas Wicovsky; Nicole Müller; Daniela Siegmund; Volker Spindler; Jens Waschke; Christian Kneitz; Harald Wajant
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

6.  In Silico Target Prediction of Overexpressed microRNAs from LPS-Challenged Zebrafish (Danio rerio) Treated with the Novel Anti-Inflammatory Peptide TnP.

Authors:  Geonildo R Disner; Maria A P Falcão; Carla Lima; Monica Lopes-Ferreira
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

7.  Nuclear factor kappa B activation occurs in the amnion prior to labour onset and modulates the expression of numerous labour associated genes.

Authors:  Sheri Lim; David A MacIntyre; Yun S Lee; Shirin Khanjani; Vasso Terzidou; T G Teoh; Phillip R Bennett
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

8.  Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine.

Authors:  Igor Popov; Mu Li; Xiufen Zheng; Hongtao San; Xusheng Zhang; Thomas E Ichim; Motohiko Suzuki; Biao Feng; Costin Vladau; Robert Zhong; Bertha Garcia; Gill Strejan; Robert D Inman; Wei-Ping Min
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Apigenin Modulates Dendritic Cell Activities and Curbs Inflammation Via RelB Inhibition in the Context of Neuroinflammatory Diseases.

Authors:  Rashida Ginwala; Raina Bhavsar; Patrick Moore; Mariana Bernui; Narendra Singh; Frank Bearoff; Mitzi Nagarkatti; Zafar K Khan; Pooja Jain
Journal:  J Neuroimmune Pharmacol       Date:  2020-06-30       Impact factor: 7.285

10.  Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways.

Authors:  Vincent F-S Shih; Jeremy Davis-Turak; Monica Macal; Jenny Q Huang; Julia Ponomarenko; Jeffrey D Kearns; Tony Yu; Riku Fagerlund; Masataka Asagiri; Elina I Zuniga; Alexander Hoffmann
Journal:  Nat Immunol       Date:  2012-10-21       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.